This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. A series of proposed bills would widen how much care California’s mid-level health workers could give to patients in order to meet the growing demand for health care services as the health law takes hold.Los Angeles Times: Lawmaker Wants To Expand Roles Of Medical ProfessionalsCiting a doctor shortage in California, a state lawmaker wants to expand the roles of nurse practitioners, pharmacists and optometrists to help treat what is expected to be a crush of newly insured Californians seeking care next year under the federal health care law. At a news conference at a community clinic here, state Sen. Ed Hernandez (D-West Covina) announced plans Wednesday to introduce a series of bills that would redefine professional boundaries for certain mid-level health workers, allowing them to provide more services than currently allowed under state law (Mishak, 3/13). Sacramento Bee: CA Lawmakers Look To Expand Scope Of Some Medical ProfessionalsCiting a need for more medical professionals able to treat patients who will soon have health insurance under the federal Affordable Care Act, state Sen. Ed Hernandez on Wednesday introduced a package of bills to expand the services that optometrists, pharmacists and nurse practitioners can offer patients. The so-called “scope of practice” bills set the stage for a massive fight with the state’s physicians, who will look to protect their role as gatekeepers to medical care. In a news conference at a Sacramento health clinic, Hernandez, an optometrist, argued that because of a shortage of doctors in California, other medical professionals should be permitted to offer patients more care (Rosenhall, 3/14). While some officials worry about who will care for patients, others worry about future holes in California’s safety net coverage –California Healthline: As Mass. Goes, So Goes California? Questioning The Safety Net’s Future”What will happen to safety-net health care facilities when their patients obtain insurance?” That’s one of many questions that county officials in California are asking about how the Affordable Care Act will affect health centers that serve patients regardless of ability to pay. The possibility of losing patients because of the ACA — and of losing funding under state proposals to expand Medi-Cal, California’s Medicaid program — have led some to wonder what will become of the health centers. The future may be bleak in the eyes of some California officials, but health reform efforts in Massachusetts tell a different story (Wayt, 3/13).Health coverage in California is also at issue for illegal immigrants and those with autism –Los Angeles Times: Illegal Immigrants Should Have Health Coverage, Foundation SaysThe California Endowment is launching a campaign to extend medical coverage to all uninsured state residents, including undocumented immigrants. An estimated 3 million to 4 million Californians, or about 10 percent of the state’s population, could remain uninsured even after the national health care overhaul takes full effect in January (Chang, 3/13).California Healthline: Administrative Law Office Oks Autism MeasuresThe California Office of Administrative Law on Monday approved emergency regulations governing health insurers’ treatment of autism coverage. The regulations were issued by the Department of Insurance to implement details of the California Mental Health Parity Act as well as to implement SB 946 by Sen. Darrell Steinberg (D-Sacramento), an autism treatment law passed in 2011. “These emergency regulations will ensure that insurance companies cover medically necessary treatment,” Insurance Commissioner Dave Jones said in a written statement (Gorn, 3/13). Calif. Lawmaker Pushes Expanded Role For Mid-Level Health Professionals
Every week reporter Ankita Rao selects interesting reading from around the Web.Newsweek: The Body-Data CrazeToday, I’ve been on the phone four times, for an average of 24 minutes a call. My last phone call was 22 minutes 23 seconds long, according to the digital time device on my landline. It took me exactly 45 minutes and 10 seconds on the train to reach Brooklyn the other night: I counted the seconds off on my smart phone. My average mile when I ran 5K yesterday was 8 minutes and 45 seconds that showed up on the pedometer. (Nothing to boast about, I know.) … I am able to hold my plank at the gym for 54 seconds rather than the minute I always thought I could, which I know thanks to my phone’s stopwatch. My optimal sleep time is seven hours and 20 minutes and I wake up twice a night: I discovered that from a wristband that measures sleep duration and intensity. … Welcome to my biography, 2013-style. It includes more data points than it possibly could have 20 years ago. And it’s part of a national obsession of a people who, literally, number our days. According to a recent nationwide survey for Pew Research Center Internet & American Life Project, 7 out of 10 people self-track regularly – using everything from human memory to a memory stick – some aspect of health for themselves or for someone else (Alissa Quartz, 6/26).Wired: Healthcare Is Broken. And This Designer Thinks She Can Fix ItHealthcare is notorious for being technophobic, clunky and downright ugly. No one knows this better than Gretchen Wustrack, who is trying desperately to change that. Wustrack, who leads the Active Health group at the design and innovation firm IDEO in San Francisco, has spent 12 years trying to give the healthcare sector a much needed facelift through design. Her approach is part of a growing movement called human-centered design, which aims to redefine how people experience healthcare by focusing on their specific needs (Daniela Hernandez, 6/24).The New York Times: The Suicide DetectiveFor reasons that have eluded people forever, many of us seem bent on our own destruction. Recently more human beings have been dying by suicide annually than by murder and warfare combined. Despite the progress made by science, medicine and mental-health care in the 20th century — the sequencing of our genome, the advent of antidepressants, the reconsidering of asylums and lobotomies — nothing has been able to drive down the suicide rate in the general population. … That curiosity has made [Matthew K. Nock, the director of Harvard University’s Laboratory for Clinical and Developmental Research] 39, one of the most original and influential suicide researchers in the world. In 2011, he received a MacArthur genius award for inventing new ways to investigate the hidden workings of a behavior that seems as impossible to untangle, empirically, as love or dreams (Kim Tingley, 6/26).The Atlantic: The LGBT Health Movement, 40 Years Since Homosexuality Was A Mental IllnessAt the time of the 1973 declassification of homosexuality as a mental illness, people joked that never in history had so many “sick” people been cured so quickly. Forty years later, health researchers across the U.S. are still assessing the ongoing fallout of discrimination on LGBT health. … While we are learning that most members of the LGBT community cope remarkably well, considering what many have lived through, there’s also promise in several health movements that are developing evidence-based interventions to further optimize resilience (John-Manuel Andriote, 6/26).The New York Times: American Way Of Birth, Costliest In The WorldSeven months pregnant, at a time when most expectant couples are stockpiling diapers and choosing car seats, Renée Martin was struggling with bigger purchases. At a prenatal class in March, she was told about epidural anesthesia and was given the option of using a birthing tub during labor. To each offer, she had one gnawing question: “How much is that going to cost?”… Like Ms. Martin, plenty of other pregnant women are getting sticker shock in the United States, where charges for delivery have about tripled since 1996, according to an analysis done for The New York Times by Truven Health Analytics. Childbirth in the United States is uniquely expensive, and maternity and newborn care constitute the single biggest category of hospital payouts for most commercial insurers and state Medicaid programs. The cumulative costs of approximately four million annual births is well over $50 billion (Elisabeth Rosenthal, 6/30). Weekend Reading: A Researcher’s Quest To Lower Suicide Rates This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Warren Buffett said he will “continue to cheer from the sidelines for our friends at Home.”Getty Images Share this storyWarren Buffett bows out of Canada’s Home Capital — and the stock dives Tumblr Pinterest Google+ LinkedIn Bloomberg News What you need to know about passing the family cottage to the next generation Sponsored By: 0 Comments ← Previous Next → advertisement Katherine Chiglinsky and Natalie Wong Email Twitter Featured Stories Warren Buffett bows out of Canada’s Home Capital — and the stock dives ‘We will continue to cheer from the sidelines for our friends at Home’ Reddit December 19, 20181:11 PM EST Filed under News FP Street Join the conversation → Comment More Facebook Warren Buffett’s role in the saga of Home Capital Group, the embattled Canadian alternative lender, is coming to a close, with Berkshire Hathaway Inc. saying it will “substantially exit” its investment in the company. Home Capital shares plunged.More than a year after taking a stake in Home Capital to shore up confidence after a near collapse, Buffett’s Berkshire Hathaway will hold less than 10 per cent of the company when the lender completes a repurchase of shares on Friday, according to a statement Wednesday. Home Capital shares dropped as much as 19 per cent, their biggest intraday decline since April 2017.Buffett swooped in last year to take a stake in the company and provide it with a $2 billion credit line, which replaced an existing emergency credit facility. The bet paid off: The original purchase of the shares was at $9.55 each in June of 2017, and Friday’s repurchases will be at a price of at least $16.50, according to a separate statement. That represents a gain of 73 per cent.‘Like the perfect storm’: An FP Investigation into the events that took Home Capital to the brinkHome Capital plans to keep rebuilding the lender after Buffett’s second tranche rejectedISS recommends Home Capital shareholders vote against the second equity placement to Warren Buffett’s Berkshire HathawayStill, the billionaire investor didn’t get all he had hoped for in the deal. He had agreed to buy shares in two transactions, one of which required shareholder approval. That bid, which would have doubled his stake, was rejected in September 2017.That failed effort and the repayment of the credit line mean the investment is “now not of a size to justify our ongoing involvement,” said Buffett, whose company was Home Capital’s largest shareholder, with a 20 per cent stake, prior to the planned sale. He isn’t leaving on sour terms. The billionaire praised Home Capital’s leadership and said Berkshire will continue to “cheer from the sidelines,” he said in the statement.Home Capital’s management team found out about Berkshire’s plans on Tuesday after the close of trading. The company is doing “fine” and is optimistic about 2019, chief executive Yousry Bissada said in an interview.“Our volumes have continued to go up in 2018. We expect to continue on that path for 2019,” Bissada said by phone. “With more efficient capital behind us, we expect it’ll be a better return for shareholders, and we’re going to continue to fine-tune capital.”Bloomberg’s David Scanlan contributed to this report.Bloomberg.com Recommended For YouRyanair CEO says confident in ‘great’ Boeing 737 MAX despite delaysGerman yields fall to day’s lows after disappointing ZEW dataBleak German mood weighs on Europe, Brexit pummels poundDemand for new designer’s ranges lift Burberry sales and sharesEuro drops as German investor morale darkens, Swiss franc nears 2019 high
Author Liberty Access TechnologiesPosted on November 22, 2018Categories Electric Vehicle News Car2go Announces Car Sharing In Paris: 400 Smart EQ Fortwo Malta’s First Car Sharing Club Introduces 150 Renault ZOE Source: Electric Vehicle News Zipcar intends to switch to 100% electric cars by 2025.The problem is that London is lacking fast chargers and some were not installed because they are considered “too ugly” for some boroughs, according to Jonathan Hampson, General Manager for Zipcar UK. Hampson said that the city promised “huge” targets for the number of DC fast chargers, but have failed to materialize.““Only a fraction of what we were told would be installed have been put in,” he said, “and it’s really because, between the boroughs and City Hall they haven’t reached agreement on where they should go; how they’re going to be put in. The boroughs don’t want them on their land because they perceive them to be ugly.”Hampson acknowledged that Transport for London (TfL) is installing rapid chargers on red routes – a network of major roads that make up 5% of the total, but carry up to 30% of the city’s traffic and therefore have tight controls on parking and loading – but said these locations were “probably the least suitable place for them to go.”He added: “I just think, at some point or other we need to get over these – what are in many senses – quite petty arguments, in the grand scheme of some of the issues we’ve got. Why does London make life so difficult when the issues we’ve got are so big?””Because the new installations are way behind the increase of EV sales, Londoners note problems with charging infrastructure (some 60% don’t have a garage or driveway).Currently, there are some 4,000 charging points in London, including 100 DC fast chargers (at least 300 should be ready by the end of 2020).Source: driving.co.uk Maybe it’s the right time to open a business of that makes only stylish chargers?Zipcar notes delays of expansion of the fast charging infrastructure in London, apparently caused by ‘petty’ arguments from the authorities.The car-sharing company operates 2,800 cars in the city, including 75 Volkswagen Golf GTE plug-in hybrids and recently added 325 Volkswagen e-Golfs.The e-Golfs became very popular, as during the first three months they were used by 6,000 drivers on over 20,000 trips.See Also Zipcar Orders 325 Volkswagen e-Golfs For Fleet In London
There are still a lot of myths and misunderstandings about EV infrastructure.Few people in the EV business have as much experience as Darryll Harrison. Before becoming ChargePoint’s director of global communications in 2016, Harrison managed comms for the launch of three different electric vehicles. He worked at Nissan in 2008 and 2009 leading up to the launch of the LEAF. Then he had a brief stint at ill-fated Coda in 2010 before moving to Volkswagen to introduce the first generation E-Golf.More about Public EV Charging Greenlots and ChargePoint Announce Charger Roaming Deal Source: Electric Vehicle News Electrify America’s New Campaign Aims To Increase EV Public Awareness I spoke with Harrison last week to discuss his decade in the field. Back in the day, he said, “You had a lot of early adopters that were totally into sustainability.” Now, Harrison said, battery-electric vehicles have expanded from small hatches to SUVs and every other segment. “The practical nature of EVs is starting to resonate.”ChargePoint was founded in 2007. Harrison said that its recent growth has been dramatic – essentially matching the rise in the number of EVs on the road. Just in the two years since Harrison joined, the staff has expanded from about 220 employees to approximately 550 spread across the globe.For Harrison, fueling patterns for an EV are more like charging a phone rather than the chore of gassing up a combustion car when the tank approaches Empty. “You don’t wait for your batteries to go dead,” he said. “The more people have EVs the more they’re going to want to charge where they are.”Here are a few other things I gleaned from the conversation.EV Charging Is an Amenity – Not a Standalone BusinessHarrison said that more than one-third of ChargePoint stations today are free. “We don’t make money selling electricity, and we don’t encourage most of our customers to make money on electricity,” he said. ChargePoint’s business is selling charging hardware, as well as the software solutions to maintain the stations. It’s the station owners who determine the price – not ChargePoint.When charging is offered at a workplace, it’s an employee perk. When it’s available at public locations (like a hotel or big-box store), it’s intended to attract and retain customers. Tesla and Electrify America networks help sell more EVs. When the owners add a cost, it’s usually to make sure drivers don’t occupy the space longer than necessary.EV Stations Are Invisible“When I speak with journalists or friends, the refrain is that lack of infrastructure is an obstacle to EV mass adoption,” said Harrison. In response, Harrison asks them to take out their phone and do a search for a charging station close to their home – only to discover locations are nearby and abundant. “They usually say, ‘I didn’t realize they were there.” In other words, there are probably hundreds of available charging stations right around you. But because there’s no big canopy like at a gas station, people don’t realize that they’re there.The implication – my words, not Harrison’s – is that lack of EV infrastructure is over-hyped.Shoppers often stay longer and spend more money when they are charging.Level-2, 240-Volt Rules. Ultra-Fast Charging Is Rarely Used.Harrison said that ChargePoint’s CPE 250, a 62.5-kilowatt DC public charger, is now rolling out. It’s part of a broad platform of ultra-fast charging solutions called Express Plus, which is in Beta development. Harrison said that fast charging right now is “somewhere in the neighborhood of five to 10 percent of charging.”He explained that ChargePoint anticipates that ultra-fast charging will be increasingly used both for longer trips between destination cities, as well as for occasional opportunistic top-ups in urban hubs. “But we don’t see that being the norm,” he said. Besides, Harrison added, “There are no cars on the road today that can accept anywhere near 350 kilowatts.”Charging Is Already Interoperable“We have a lot of Tesla drives charging on our network,” said Harrison. “There’s data to suggest that a lot of them charge on ChargePoint the same if not more than on Tesla’s Supercharger network.” Again, that’s because people rarely use fast charging as their primary source of electricity.Also, ChargePoint has agreements with EV Box, Greenlots, and Canada’s Flo Network to allow EV drivers to roam between networks without needing separate accounts. Harrison doesn’t believe that charging stations are all moving toward use of a credit-card reader. “It’s going the other direction, so that use your phone to start a session,” he said. “I don’t take my wallet with me when I go to the grocery store. I use Apple Pay.”Fleets Will Push Expansion of EV MarketChargePoint is expanding its fleet business. What’s driving this direction is municipalities and transit authorities working to electrify their fleets – and the rise of ride-hailing, delivery platforms, and car-sharing services. Harrison believes all this activity will take time, but it’s a positive development for EVs. “It might not happen in the next five to 10 years, but as a company, we see that as a shift in mobility, and we are preparing,” he said.Electric vehicles offer direct business benefits for fleet managers to lower fuel and maintenance costs. As consumers, we usually focus on individual vehicles but ultra-green, low-cost electric fleets can electrify faster and therefore play a major role in EV expansion. ChargePoint CEO On Tesla Superchargers & The Future Of EV Charging Author Liberty Access TechnologiesPosted on January 29, 2019Categories Electric Vehicle News
Source: InsideEvsEurope and China are much larger markets for Model 3 and the company will need some time to get its delivery network in shape to handle the volume. Tesla has reiterated its guidance of “360,000 to 400,000 vehicle deliveries in 2019”, and it’s clear that Tesla will be banking on Model 3 sales in Europe and China to help achieve that goal.===Author Bio: Shankar Narayanan is the editor of 1redDrop.com. Has an MBA from Kent State University and an engineering degree from Madurai Kamaraj University. He has been an active contributor to top financial sites like SeekingAlpha and GuruFocus, and has a penchant for talking business, finance, and technology.*Editor’s Note: EVANNEX, which also sells aftermarket gear for Teslas, has kindly allowed us to share some of its content with our readers, free of charge. Our thanks go out to EVANNEX. Check out the site here. *This article comes to us courtesy of EVANNEX (which also makes aftermarket Tesla accessories). Posted by Shankar Narayanan. The opinions expressed in these articles are not necessarily our own at InsideEVs. Lead Image Source: Alphr.Tesla also reported that in the last three months it delivered 63,000 Model S, Model X, and Model 3 (while producing 77,100 vehicles), falling short of the average analyst delivery estimate of 73,500.Even if Tesla managed to deliver all the cars the company had manufactured between January and March 2019, it would have still fallen short of the fourth-quarter 2018 sales record of 90,700 units. Tesla cited delivery bottlenecks in Europe and China as a reason for its lower-than-expected deliveries.The company said, “Due to a massive increase in deliveries in Europe and China, which at times exceeded 5x that of prior peak delivery levels, and many challenges encountered for the first time, we had only delivered half of the entire quarter’s numbers by March 21, ten days before the end of quarter. This caused a large number of vehicle deliveries to shift to the second quarter. At the end of the first quarter, approximately 10,600 vehicles were in transit to customers globally.”Even though Tesla’s Q1-19 deliveries increased by 110% compared to the first quarter of 2018, we’ve been getting used to the company reporting massive sequential increases in quarterly deliveries. But this time Tesla broke its sequential growth winning streak after six quarters. The last time Tesla missed out on reporting a sales increase in the following quarter was during the second quarter of 2017 when the company was yet to begin Model 3 production. Source: ir.tesla.comApart from the 10K+ units that were in the transit, Tesla lost sales of 10k units in the form of Model S and X. The drop in deliveries of higher priced Model S and Model X will certainly put additional pressure on Tesla’s quarterly revenue as well as its operating margins.Tesla started off the quarter with $3.7 billion cash on hand and the company had to pay off a $920 million bond in March. The launch of Model Y and overseas expansion-related expenses will further impact the company’s cash balance in the first quarter. The drop in deliveries is going to hurt first-quarter revenue and could conceivably end up transitioning Tesla’s net income into the red.The first quarter of 2019 now looks like a bit of a difficult pill to swallow for investors, but it’s certainly not a dire scenario that necessitates panic.Tesla started Model 3 deliveries in Europe in early February and China in late February. Tesla’s struggle to deliver cars in North America during the ramp-up of Model 3 production in 2018 has been well documented, and the company took several months to get its logistics in order. March 2019 U.S. EV Sales Continue The Trend, Barely Exceeding 2018 Tesla Model 3, S, X March 2019 U.S. Sales Estimates: Final March 2019 U.S. Plug-In EV Sales Report Card Author Liberty Access TechnologiesPosted on April 5, 2019Categories Electric Vehicle News Source: 1reddropBut Tesla’s problem during the first quarter was not just the number of Model 3 units that got caught in transit; production and delivery of flagship vehicles Model S and Model X also took a significant hit, knocking down Tesla’s overall numbers. TESLA’S Q1-19 DEFINITELY HURT, BUT DON’T PANICTesla’s first-quarter deliveries dropped by 31% compared to the previous quarter as the Elon Musk-led company struggled to deliver cars to customers in international markets. The company said that approximately 10,600 cars were in transit, compared to 2,907 cars that were in transit at the end of the fourth quarter of 2018.Additional EV Sales Content: Source: Electric Vehicle News
“In June 2011, an anonymous source reported, through our confidential ethics hotline, that our majority-owned joint venture in Kenya may have made certain improper payments. In July 2011, an employee of our subsidiary in Angola reported that similar improper payments may have been made in Angola. Outside counsel and forensic accountants were retained to investigate the alleged improper payments in Kenya and Angola, including our compliance in those countries with the U.S. Foreign Corrupt Practices Act. We do not believe that the amount of the payments in question in Kenya and Angola, or any revenue or operating income related to those payments, are material to our business, results of operations, financial condition or liquidity.As a result of our review of these matters, we have implemented, and are continuing to implement, appropriate remedial measures and have voluntarily disclosed the results of our initial investigation to the U.S. Department of Justice and the Securities and Exchange Commission, and are cooperating with those agencies in their review of these matters. As a result of ongoing discussions with the government, we have recorded a charge of $16 million in connection with these matters in the third quarter of 2014. While we currently estimate that the most likely amount of the loss associated with these matters is approximately $16 million, the actual amount of the loss could vary, and the timing of any resolution and payment cannot yet be determined.” Key Energy ServicesHere is what the company disclosed about its third quarter expenses associated with its FCPA investigation.“The results for the third quarter include a pre-tax charge of $60.8 million, or $0.25 per share, for an impairment of the Company’s U.S. assets and pre-tax costs of $16.1 million, or $0.07 per share, related to the previously disclosed Foreign Corrupt Practices Act (“FCPA”) investigations.”Doing the math, that is approximately $243,000 in professional fees and expenses per working day.AvonAvon has been under FCPA scrutiny since June 2008. As highlighted here, in May 2014 the company disclosed that it and the DOJ/SEC reached an agreement in principle to resolve FCPA enforcement actions for an aggregate amount of $135 million. Approximately six months later, there has still yet to be an enforcement action. Yesterday, Avon disclosed: Scrutiny updates, the story of the FCPA, keep it simple, and for the reading stack. It’s all here in the Friday roundup.Scrutiny UpdatesGoodyearGoodyear Tire & Rubber Co. has been under FCPA scrutiny for approximately three years concerning conduct in Kenya and Angola. Earlier this week the company disclosed: “As previously reported, we have reached an understanding with respect to terms of settlement with each of the DOJ and the staff of the SEC. Based on these understandings, the Company would, among other things: pay aggregate fines, disgorgement and prejudgment interest of $135 with respect to alleged violations of the books and records and internal control provisions of the FCPA, with $68 payable to the DOJ and $67 payable to the SEC; enter into a deferred prosecution agreement (“DPA”) with the DOJ under which the DOJ would defer criminal prosecution of the Company for a period of three years in connection with alleged violations of the books and records and internal control provisions of the FCPA; agree to have a compliance monitor which, with the approval of the government, can be replaced after 18 months by the Company’s agreement to undertake self monitoring and reporting obligations for an additional 18 months. If the Company remains in compliance with the DPA during its term, the charges against the Company would be dismissed with prejudice. In addition, as part of any settlement with the DOJ, a subsidiary of Avon operating in China would enter a guilty plea in connection with alleged violations of the books and records provision of the FCPA. The expected terms of settlement do not require any change to our historical financial statements.Final resolution of these matters is subject to preparation and negotiation of documentation satisfactory to all the parties, including approval by our board of directors and, in the case of the SEC, authorization by the Commission; court approval of the SEC settlement; and court approval of the DPA and acceptance of the expected guilty plea by an Avon subsidiary operating in China. We can provide no assurances that satisfactory final agreements will be reached, that authorization by the Commission or the court approvals will be obtained or that the court will accept the guilty plea or with respect to the timing or terms of any such agreements, authorization, and approvals and acceptance.”“The Story of the FCPA”Assistant Attorney General Leslie Caldwell’s recent speech (see here for the prior post) has generated follow-up discussion at the FCPA Blog (here and here), including as to the motivation of Congress in passing the law.Read the “story” of the FCPA for yourself. This article weaves together information and events scattered in the FCPA’s voluminous legislative record to tell the FCPA’s story through original voices of actual participants who shaped the law.Keep it SimpleOver at thebriberyact.com, this post begins:“Three years ago Bribery Inc. went mad. Every law firm, accounting firm and uncle Tom Cobley and all got into the anti bribery business. Many detailed anti-bribery policies were sold, placed on corporate intranets and training given. Three years on and many are reviewing their policies and looking back at how they’ve been operating for the last three years. This is a sensible thing to do. Many anti-bribery policies are extensive. […] We could go on. And many policies do. And this is where they go wrong. Because the longer they are the less likely it is anyone will read them or even know where to find them.”Referencing comments made by U.K. Serious Fraud Office Director David Green, the post states:“The SFO Director said that he doesn’t really like long anti-bribery policies. Broadly speaking he is concerned that they probably won’t be read or understood by employees. The obvious consequence of the anti-bribery policy not being read is that it is unlikely to be followed. His observation and the concern which underpins it resonates with us.”It resonates with me as well. (See this previous post titled “Compliance Fatigue?”).That is why my global anti-bribery online training course (created in conjunction with Emtrain) keeps things simple. To see how the course engages employees in a business organization and inspires them to spot risk (see this video). To see how the course trains gatekeepers in a business organization to minimize risk (see this video).Reading StackThomas Fox (FCPA Compliance and Ethics Blog) is out with a new book titled “Doing Compliance: Design, Create, and Implement an Effective Anti-Corruption Compliance Program.” (See here for more information).The latest FCPA Update from Debevoise & Plimpton is here.Dorsey & Whitney’s Anti-Corruption Digest (Oct. 2014) is here.Sidley & Austin’s Anti-Corruption Quarterly is here.*****A good weekend to all.
by, Kavan Peterson, Editor, ChangingAging.orgTweetShareShareEmail0 Shares Manchester Town HallTaking a mid-way break from his Age of Disruption 2015 US tour, Dr Bill Thomas visits Halifax, Canada June 12 and then the United Kingdom June 15-19 to challenge ageing stereotypes and talk about how organizations can meet the needs of a savvy older consumer.Dr. Thomas visited Halifax to speak at the Nova Scotia 50 Plus Expo. Click here to see Dr. Thomas and Expo Chair Valerie White interviewed on CTV.Dr. Thomas tours the UK on behalf of Evermore, a UK-based adaption of The GREEN HOUSETM model of long term care. Dr. Thomas serves as global chair for Evermore and will help launch a new program designed by the Evermore Academy aimed at revolutionizing lifestyles in older age through a radical approach to people development called GREEN HOUSE PEOPLE TM.The program aims to build a culture of autonomy, mastery, and power within Britain’s social care workforce, said Evermore Founder and Market Innovation Director Sarah McKee.Visit the Tour website www.drbillthomas.com to learn more about Age of Disruption UK. Related PostsAge of Disruption 2016 World TourWe are excited to announce that Dr. Bill Thomas and the Center for Growing and Becoming have committed to continuing the Age of Disruption Tour in 2016 and 2017!Last Chance to Play Life’s Most Dangerous GameOnly three more Tour stops in 2015 for Dr. Bill Thomas’ Age of Disruption Tour! Click here to buy tickets for his signature “non-fiction” theater performance Life’s Most Dangerous Game this week only in Florida.WGN Morning News: Age of Disruption Comes to ChicagoDr. Bill Thomas appeared on WGN Chicago Morning News and the first question was about ageism. Video coming soon, click here for details on Dr. Thomas’ May 8 Chicago performance for the Age of Disruption Tour.TweetShareShareEmail0 SharesTags: Age of Disruption evermore UK
Source:https://www.marshall.edu/ucomm/2018/07/26/marshall-school-of-pharmacy-school-of-medicine-researchers-identify-inflammatory-biomarkers-in-t-cells/ Jul 31 2018The Marshall University School of Pharmacy, in collaboration with the Marshall University Joan C. Edwards School of MedicineGenomics Core, recently released a new study that explores human T cell function under inflammatory conditions.The findings are published in the July 19, 2018, edition of Scientific Reports, an online journal from the publishers of Nature.Related StoriesNew shingles vaccine reduces outbreaks of painful rash among stem cell transplant patientsExciting study shows how centrioles center the process of cell divisionNanoparticles used to deliver CRISPR gene editing tools into the cell”Our gene expression analysis of T cells provides many possible targets for studying how environmental products control T cell activation and pro-inflammatory functions,” said Jeremy P. McAleer, Ph.D., lead author and assistant professor at the Marshall School of Pharmacy. “We were encouraged to find that one of these targets, named GPR68, regulates the ability of T cells to produce chemical messengers. This may have implications for diseases on mucosal surfaces such as the lungs and gastrointestinal tract.”The study examined T cells, which protect against bacteria, fungi and viruses on mucosal surfaces. When activated against harmless substances, T cells may provoke autoimmune diseases. Findings reveal that the set of genes expressed by T cells under pro-inflammatory conditions include several G-protein-coupled receptors (GPRs). Future studies will explore if blocking the GPR68 pathway can be a potential therapy for chronic inflammatory diseases.
Source:https://newsroom.wiley.com/press-release/journal-bone-and-mineral-research/can-community-exercise-help-prevent-bone-loss-associ Aug 9 2018In a Journal of Bone and Mineral Research study of older adults with obesity who were cutting calories, an intervention that incorporated resistance training, aerobic training, or neither did not prevent bone loss associated with active weight loss. The study’s results suggested that resistance training may help minimize long-term hip bone loss, however.”If minimizing bone loss during active weight loss proves necessary to offset long-term skeletal fragility, then our results suggest that resistance exercisemay need to be coupled with other intervention strategies to maximize skeletal benefit,” said lead author Dr. Kristen Beavers, of Wake Forest University.Additional research should seek to elucidate the mechanisms underlying weight-loss-induced bone loss, so that, safe and effective strategies can be designed to preserve all aspects of bone health in dieting older individuals.
Related StoriesITL Group returns to MEDICA 2017 to discuss future of diagnostic devicesITL Group proud of passing latest FDA auditUniversity of Tennessee researchers use Vitl’s Lu-mini in watermelon snow research projectThe TSM A70 Series is the latest addition to ITL’s electronics department, which is also home to the new, fully programmable StripCrimp 200 – suitable for high precision stripping and subsequent crimping of side- or rear-feed terminals for wires between 0.05 – 4.00 mm² (30 – 12 AWG).Features: This investment is part of our commitment to continuous improvement and enables us to retain our reputation for delivering superior quality manufacturing services to our customers.” Aug 24 2018Experienced medical device design, development, and manufacturing partner, ITL Group (a Gooch & Housego company) has announced further investment in its on-site PCB manufacturing facility.With more than 40 years PCB manufacturing experience, ITL is one of the few ISO13485 and FDA GMP certified UK companies that can provide high volume PCB manufacturing within the medical sector.ITL has invested in the TSM A70 Series, a SMT reflow oven, alongside a five-day training course for four SMT Operators. These recent advancements are part of ITL’s commitment to continuous improvement.Tristan Lambert, Production Manager, ITL Group said: TSM ovens feature ultra-low power consumption Temperature Monitoring Function – Measured, actual temperature is indicated by on-screen display with any differences clearly illustrated by changing on-screen colours and alarm. Automatic Conveyor Adjustment, Chain Oiler and Start-Stop Entire Reflow System is controlled through the on-board PC – This includes the heater temperature, blower fan, and convection velocity. Sets the optimum profile and system checks if the set profile is maintained within the error range by measuring the temperature in the oven in real time (alarm sounds if there is an error). Temperature profile memory for each product; no time loss when changing production model, making a separate profile check unnecessary. Source:https://www.itlmedical.com/
Source:https://www.escardio.org/The-ESC/Press-Office/Press-releases/extended-use-of-oral-anticoagulant-after-hospital-discharge-reduces-non-fatal-blood-clots Reviewed by James Ives, M.Psych. (Editor)Aug 27 2018The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.Professor Alex Spyropoulos, study author, of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New York, US, said: “Anticoagulants help prevent blood clots in medically ill patients while they are under our supervision at the hospital. However, the risk of blood clots extends well beyond this period. Our results suggest we may be able to offer further protection to patients at risk from non-fatal blood clots, with no increase in major bleeding, by prescribing an oral anticoagulant for use after discharge. This study has potential to reduce the public healthcare burden of non-fatal blood clots in a large proportion of medically ill patients.”Each year, around 20 million acutely ill medical patients are hospitalised in the US and EU with conditions such as heart attack, pneumonia, flu, bronchitis, asthma, or broken bones. A significant proportion of these patients are at risk of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, while in hospital and up to six weeks afterwards. Around 70% of hospital-acquired fatal pulmonary embolism occurs in medically ill patients.Anticoagulants delivered by intravenous drip or injection are recommended to prevent blood clots (called thromboprophylaxis) in medically ill patients while in hospital, but guidelines do not recommend any use of anticoagulants post-discharge. However, after leaving the hospital the rate of symptomatic VTE more than doubles over the first 21 days and is associated with a five-fold increased risk of fatal pulmonary embolism within 30 days post-discharge.The MARINER trial investigated whether continuing thromboprophylaxis with an oral anticoagulant after discharge could reduce the risk of symptomatic VTE and VTE-related death in medically ill patients at risk for VTE. The trial enrolled 12,024 patients from 671 centres in 36 countries. Patients were 40 years of age or older, had been hospitalised for an acute medical illness, and had other risk factors for VTE as defined by a VTE risk score that included immobilisation for one day or longer, being in intensive care, age over 60 years, limb paralysis, previous VTE, thrombophilia or a D-dimer level more than two times the upper limit of normal.Related StoriesDanbury Hospital launches ‘Healing Hugs’ for its most vulnerable patientsFeeling safe and good sleep at night matter most to sick kids in hospital’Traffic light’ food labels associated with reduction in calories purchased by hospital employeesPatients were randomly allocated to a 45-day course of either once daily oral rivaroxaban 10 mg (7.5 mg in patients with reduced kidney function) or placebo at the time of hospital discharge. The primary efficacy outcome was symptomatic VTE and VTE-related death. The principal safety outcome was major bleeding.The final analysis included 12,019 patients, of whom 11,962 (99.5%) had taken at least one dose of study drug. The average age was 69.7 years and 48% were female. Four in ten patients had been admitted to hospital for heart failure, 27% for respiratory insufficiency, 17% for infectious disease, 14% for ischaemic stroke, and 2% for inflammatory disease.During the 45-days post-discharge, 50 (0.83%) patients taking rivaroxaban had symptomatic VTE or died from VTE-related causes compared to 66 (1.1%) taking placebo (p=0.136). When examining symptomatic VTE only, which included lower extremity DVT and non-fatal pulmonary embolism, there were fewer events with rivaroxaban (0.18%) compared to placebo (0.42%; hazard ratio [HR] 0.44, 95% confidence interval [CI] 0.22-0.89, p=0.023).The researchers also examined an exploratory secondary composite endpoint of symptomatic VTE and all-cause mortality and found that 1.3% of patients taking rivaroxaban experienced an event compared to 1.78% of patients in the placebo group (HR 0.73, 95% CI 0.54-0.97, p=0.033).Major bleeding occurred in 17 (0.28%) patients in the rivaroxaban group compared to nine (0.15%) taking placebo (p=0.124), with very few critical and fatal bleeds and no significant difference between groups.
A well-fed female mantis is irresistible to a male. She’s chock-full of eggs and draws him in by producing high levels of pheromones. Now, a new study reveals that starving females can deceive males by enticing them to their doom. Researchers have found that female false garden mantises (Pseudomantis albofimbriata, pictured) that were fed just a quarter of what others got actually produced more pheromones than well-fed females—and attracted almost twice the number of males. This is despite the fact that the number of eggs in the starved females was less than 10, compared with more than 60 eggs in well-fed females. The finding, reported online today in the Proceedings of the Royal Society B, is the first experimental demonstration of sexual deception using false chemical signals in any animal. The starving females seem to be treating the males as easy prey to gain nutritional benefits and potentially produce more eggs.*Correction, 17 December, 3:59 p.m.: This item originally stated that fully fed female mantises are also cannibalistic. We have changed the text to reflect that they are not.